Hostname: page-component-76fb5796d-zzh7m Total loading time: 0 Render date: 2024-04-26T01:08:24.761Z Has data issue: false hasContentIssue false
  • English
  • Français

Early outcomes of conformal radiotherapy in the treatment of cavernous sinus meningioma

Published online by Cambridge University Press:  23 October 2018

R. Moujahed ,
K. Ghedira Open the ORCID record for K. Ghedira [Opens in a new window] ,
C. Drissi ,
A. Kallel  and
L. Kochbati
R. Moujahed
Affiliation:
Radiotherapy Department, Abderahmen Mami Hospital, Ariana, Tunisia
K. Ghedira*
Affiliation:
Neurosurgery Department, National Neurology Institute, Tunis, Tunisia
C. Drissi
Affiliation:
Neuroradiology Department, National Neurology Institute, Tunis, Tunisia
A. Kallel*
Affiliation:
Ennaser Private Hospital, Ennaser, Tunisia
L. Kochbati
Affiliation:
Radiotherapy Department, Abderahmen Mami Hospital, Ariana, Tunisia
*
Author for correspondence: Khalil Ghedira, Neurosurgery Department, National Institute of Neurology, Rabta 1007, Tunis. Tel: +216 50 248 298. E-mail: khalil.ghedira@gmail.com
Author for correspondence: Khalil Ghedira, Neurosurgery Department, National Institute of Neurology, Rabta 1007, Tunis. Tel: +216 50 248 298. E-mail: khalil.ghedira@gmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Aim: Cavernous sinus tumours represent 1% of all intracranial neoplasms, and 41% of them are cavernous sinus meningiomas (CSM). The disappointing results of the microsurgical approach in the treatment of CSM have led to the evaluation of a more conservative strategy, such as conformal radiotherapy (CR) and stereotactic radiosurgery (SRS). Here we report our experience with CR in the treatment of CSM, aiming to evaluate local control, clinical response and radiation-induced toxicity. Methods: A total of 18 patients with CSM, treated from 2011 to 2017, were retrospectively reviewed. Results: Patient median age was 59 years [31–74]. Clinical presentation included impaired vision, cranial nerve deficit, headache, ocular signs. Median tumour size was 35 mm [13–56]. Six patients were operated before the radiation. Twelve patients were treated with definitive radiotherapy. Dose of radiation varied from 50.4 Gy in 28 fractions, to 54 Gy in 30 fractions. Median follow-up was 33 months [6–84]. Among the 18 patients, patient’s signs and symptoms of disease remained unchanged in three cases (16.66%), 12 (66.66%) were improved and 1 patient (5.55%) exhibited tumour progression (exophthalmia). Two patients (11.11%) were lost to follow-up after the end of the treatment with radiotherapy. Findings: Based on our study findings, CR has proved to be a relatively safe and effective therapeutic option in the treatment of CSM, whether used as first-line or as an adjuvant treatment. CR may be particularly effective for tumours that are not amenable to SRS, owing to lesion size (> 30-35 mm) and/or proximity to the optic apparatus (<3 mm).

Keywords

cavernous sinusmeningiomaneurosurgeryoutcomeradiotherapy
Type
Original Article
Information
Journal of Radiotherapy in Practice , Volume 18 , Issue 2 , June 2019 , pp. 150 - 154
Check for updates
Copyright
© Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Cite this article: Moujahed R, Ghedira K, Drissi C, Kallel A, Kochbati L. (2019) Early outcomes of conformal radiotherapy in the treatment of cavernous sinus meningioma. Journal of Radiotherapy in Practice18: 150–154. doi: 10.1017/S1460396918000535

References

1. dos Santos, M A, de Salcedo, J B, Gutiérrez Diaz, J A, Calvo, F A, Samblás, J, Marsiglia, H, et al. Long-term outcomes of stereotactic radiosurgery for treatment of cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys 2011; 81: 1436–1441.Google Scholar
2. O’Sullivan, M G, van Loveren, H R, Tew, J M Jr. The surgical resectability of meningiomas of the cavernous sinus. Neurosurgery 1997; 40: 238–244.Google Scholar
3. Sindou, M, Wydh, E, Jouanneau, E, Nebbal, M, Lieutaud, T. Long-term follow-up of meningiomas of the cavernous sinus after surgical treatment alone. J Neurosurg 2007; 107: 937–944.Google Scholar
4. Sughrue, M E, Rutkowski, M J, Aranda, D, Barani, I J, McDermott, M W, Parsa, A.T. Factors affecting outcome following treatment of patients with cavernous sinus meningiomas. J Neurosurg 2010; 113: 1087–1092.Google Scholar
5. Nakamura, M, Roser, F, Jacobs, C, Vorkapic, P, Samii, M. Medial sphenoid wing meningiomas: clinical outcome and recurrence rate. Neurosurgery 2006; 58: 626–639.Google Scholar
6. Maguire, P D, Clough, R, Friedman, A H, Halperin, E C. Fractionated external-beam radiation therapy for meningiomas of the cavernous sinus. Int J Radiat Oncol Biol Phys 1999; 44: 75–79.Google Scholar
7. Nutting, C, Brada, M, Brazil, L, Sibtain, A, Saran, F, Westbury, C et al. Radiotherapy in the treatment of benign meningioma of the skull base. J Neurosurg 1999; 90: 823–827.Google Scholar
8. Goldsmith, B J, Wara, W M, Wilson, C B, Larson, D A. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994 80: 195–201.Google Scholar
9. Metellus, P, Regis, J, Muracciole, X, Fuentes, S, Dufour, H, Nanni, I, et al. Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery 2005; 57: 873–886.Google Scholar
10. Brell, M, Villa, S, Teixidor, P, Lucas, A, Ferrán, E, Marín, S, et al. Fractionated stereotactic radiotherapy in the treatment of exclusive cavernous sinus meningioma: functional outcome, local control, and tolerance. Surg Neurol 2006; 65: 28–33.Google Scholar
11. Milker-Zabel, S, Zabel-du Bois, A, Huber, P, Schlegel, W, Debus, J. Fractionated stereotactic radiation therapy in the management of benign cavernous sinus meningiomas: long-term experience and review of the literature. Strahlenther Onkol 2006; 182: 635–640.10.1007/s00066-006-1548-2Google Scholar
12. Metellus, P, Batra, S, Karkar, S, Kapoor, S, Weiss, S, Kleinberg, L, et al. Fractionated conformal radiotherapy in the management of cavernous sinus meningioma: long-term functional outcome and tumor control at a single institution. Int J Radiation Oncology Biol Phys 2010; 78: 836–843.Google Scholar
13. Iwai, Y, Yamanaka, K, Ishiguro, T. Gamma knife radiosurgery for the treatment of cavernous sinus meningiomas. Neurosurgery 2003; 52: 517–524.Google Scholar
14. Maruyama, K, Shin, M, Kurita, H, Kawahara, N, Morita, A, Kirino, T. Proposed treatment strategy for cavernous sinus meningiomas: a prospective study. Neurosurgery 2004; 55: 1068–1075 DOI: 10.1227/01.NEU.0000140839.47922.5A.Google Scholar
15. Spiegelmann, R, Nissim, O, Menhel, J, Alezra, D, Pfeffer, M R. Linear accelerator radiosurgery for meningiomas in and around the cavernous sinus. Neurosurgery 2002; 51: 1373–1379.Google Scholar
16. Liu, A L, Wang, C, Sun, S, Wang, M, Liu, P. Gamma knife radiosurgery for tumors involving the cavernous sinus. Stereotact Funct Neurosurg 2005; 83: 45–51.Google Scholar
17. Leber, K A, Bergloff, J, Pendl, G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 1998; 88: 43–50.10.3171/jns.1998.88.1.0043Google Scholar
18. Morita, A, Coffey, R J, Foote, R L, Schiff, D, Gorman, D. Risk of injury to cranial nerves after gamma knife radiosurgery for skull base meningiomas: experience in 88 patients. J Neurosurg 1999; 90: 42–49.Google Scholar
19. Spiegelmann, R, Cohen, Z R, Nissim, O, Alezra, D, Pfeffer, R. Cavernous sinus meningiomas: a large LINAC radiosurgery series. J Neurooncol 2010; 98: 195–202.Google Scholar
20. Skeie, B S, Enger, P O, Skeie, G O, Thorsen, F, Pedersen, P H. Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. Neurosurgery 2010; 66: 661–668.Google Scholar
21. Liu, A L, Wang, C, Sun, S, Wang, M, Liu, P. Gamma knife radiosurgery for tumors involving the cavernous sinus. Stereotact Funct Neurosurg 2005; 83: 45–51.Google Scholar
22. Pendl, G, Schrottner, O, Eustacchio, S, Ganz, J C, Feichtinger, K. Cavernous sinus meningiomas – what is the strategy: Upfront or adjuvant gamma knife surgery? Stereotact Funct Neurosurg 1998; 70: 33–40.Google Scholar
23. Pourel, N, Auque, J, Bracard, S, Hoffstetter, S, Luporsi, E, Vignaud, J M, et al. Efficacy of external fractionated radiation therapy in the treatment of meningiomas: a 20-year experience. Radiother Oncol 2011; 61: 65–70.Google Scholar
24. Mendenhall, W, Morris, C, Amdur, R, Foote, K D, Friedman, W A. Radiotherapy alone or after subtotal resection for benign skull base meningiomas. Cancer 2003; 98: 1473–1482.Google Scholar
25. Uy, N, Woo, S, Teh, B, Harnisch, G, Stevens, G H, Lee, J, et al. Intensity-modulated radiation therapy (IMRT) for meningioma. Int J Radiat Oncol Biol Phys 2002; 53: 1265–1270.Google Scholar
26. Pollock, B E, Stafford, S L, Link, M J, Garces, Y I, Foote, R L. Single-fraction radiosurgery of benign cavernous sinus meningiomas. Clin J Neurosurg 2013; 119: 675–682.10.3171/2013.5.JNS13206Google Scholar
27. Correa, S F, Marta, G N, Teixeira, M J. Neurosymptomatic cavernous sinus meningioma: a 15-years experience with fractionated stereotactic radiotherapy and radiosurgery. Radiat Oncol 2014; 9: 27.Google Scholar
28. Parsons, J T, Bova, F J, Fitzgerald, C R, Mendenhall, W M, Million, R R. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 1994; 30: 755–763.Google Scholar
29. Lee, J.Y.K, Niranjan, A, McInerney, J, Kondziolka, D, Flickinger, J C, Lunsford, L D. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurgery 2002; 97: 65–72.Google Scholar